Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Acta Neurologica Belgica
|
June 24, 2025
Tackling paraneoplastic and non-paraneoplastic Lambert-Eaton myastenic syndromes: when timing is key. Comment on schőn et al. report
Giuliana Galassi, Alessandra Ariatti, Marco Mazzoli, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
July 24, 2019
Surrogate Molecular Classification of Invasive Breast Carcinoma: A Comparison Between Core Needle Biopsy and Surgical Excision, With and Without Neoadjuvant Therapy
Andrea Ambrosini-Spaltro, Elena Zunarelli, Stefania Bettelli, et al.
Virchows Archiv : an International Journal of Pathology
|
October 13, 2005
Polymorphous adenocarcinoma of the breast. Report of three cases
Sofia Asioli, Gianluca Marucci, Guido Ficarra, et al.
Anticancer Research
|
July 2, 2014
Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact
Maria Vittoria Dieci, Federico Piacentini, Massimo Dominici, et al.
Breast Cancer : Basic and Clinical Research
|
May 17, 2021
Application of OSNA Nomogram in Patients With Macrometastatic Sentinel Lymph Node: A Retrospective Assessment of Accuracy
Francesca Combi, Alessia Andreotti, Anna Gambini, et al.
The International Journal of Biological Markers
|
June 15, 2010
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis
Valentina Guarneri, Elena Barbieri, Federico Piacentini, et al.
International Journal of Cancer
|
August 24, 2012
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years
Laura Cortesi, Luigi Marcheselli, Valentina Guarneri, et al.
Journal of Clinical Pathology
|
March 6, 2012
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis
Maria Vittoria Dieci, Elena Barbieri, Stefania Bettelli, et al.
The Oncologist
|
July 25, 2008
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management
Valentina Guarneri, Simona Giovannelli, Guido Ficarra, et al.
Journal of Proteome Research
|
September 11, 2009
Identification of protein clusters predictive of response to chemotherapy in breast cancer patients
Laura Cortesi, Andrea Barchetti, Elisabetta De Matteis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Acta Neurologica Belgica
|
June 24, 2025
Tackling paraneoplastic and non-paraneoplastic Lambert-Eaton myastenic syndromes: when timing is key. Comment on schőn et al. report
Giuliana Galassi, Alessandra Ariatti, Marco Mazzoli, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
July 24, 2019
Surrogate Molecular Classification of Invasive Breast Carcinoma: A Comparison Between Core Needle Biopsy and Surgical Excision, With and Without Neoadjuvant Therapy
Andrea Ambrosini-Spaltro, Elena Zunarelli, Stefania Bettelli, et al.
Virchows Archiv : an International Journal of Pathology
|
October 13, 2005
Polymorphous adenocarcinoma of the breast. Report of three cases
Sofia Asioli, Gianluca Marucci, Guido Ficarra, et al.
Anticancer Research
|
July 2, 2014
Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact
Maria Vittoria Dieci, Federico Piacentini, Massimo Dominici, et al.
Breast Cancer : Basic and Clinical Research
|
May 17, 2021
Application of OSNA Nomogram in Patients With Macrometastatic Sentinel Lymph Node: A Retrospective Assessment of Accuracy
Francesca Combi, Alessia Andreotti, Anna Gambini, et al.
The International Journal of Biological Markers
|
June 15, 2010
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis
Valentina Guarneri, Elena Barbieri, Federico Piacentini, et al.
International Journal of Cancer
|
August 24, 2012
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years
Laura Cortesi, Luigi Marcheselli, Valentina Guarneri, et al.
Journal of Clinical Pathology
|
March 6, 2012
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis
Maria Vittoria Dieci, Elena Barbieri, Stefania Bettelli, et al.
The Oncologist
|
July 25, 2008
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management
Valentina Guarneri, Simona Giovannelli, Guido Ficarra, et al.
Journal of Proteome Research
|
September 11, 2009
Identification of protein clusters predictive of response to chemotherapy in breast cancer patients
Laura Cortesi, Andrea Barchetti, Elisabetta De Matteis, et al.
Page
of 3